Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis.

Data from several studies have suggested that polymorphisms in A-kinase anchoring proteins (AKAPs), which are key components of signal transduction, contribute to carcinogenesis. To evaluate the impact of AKAP variants on breast cancer risk, we genotyped six nonsynonymous single-nucleotide polymorphisms that were predicted to be deleterious and found two (M463I, 1389G>T and N2792S, 8375A>G) to be associated with an allele dose-dependent increase in risk of familial breast cancer in a German population. We extended the analysis of AKAP9 M463I, which is in strong linkage disequilibrium with AKAP9 N2792S, to 9523 breast cancer patients and 13770 healthy control subjects from seven independent European and Australian breast cancer studies. All statistical tests were two-sided. The collaborative analysis confirmed the association of M463I with increased breast cancer risk. Among all breast cancer patients, the combined adjusted odds ratio (OR) of breast cancer for individuals homozygous for the rare allele TT (frequency = 0.19) compared with GG homozygotes was 1.17 (95% confidence interval [CI] = 1.08 to 1.27, P = .0003), and the OR for TT homozygotes plus GT heterozygotes compared with GG homozygotes was 1.10 (95% CI = 1.04 to 1.17, P = .001). Among the combined subset of 2795 familial breast cancer patients, the respective ORs were 1.27 (95% CI = 1.12 to 1.45, P = .0003) and 1.16 (95% CI = 1.06 to 1.27, P = .001).

[1]  L. Shulman,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2008 .

[2]  D. Duffy,et al.  Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies , 2008, Breast Cancer Research and Treatment.

[3]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[4]  P. Kwok,et al.  Gene-trapped mouse embryonic stem cell-derived cardiac myocytes and human genetics implicate AKAP10 in heart rhythm regulation , 2007, Proceedings of the National Academy of Sciences.

[5]  Alfons Meindl,et al.  BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study , 2007, BMC Cancer.

[6]  A. Ashworth,et al.  Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. , 2007, Human molecular genetics.

[7]  Alison M Dunning,et al.  Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk , 2007, Breast Cancer Research.

[8]  R. Kreienberg,et al.  Links between DNA double strand break repair and breast cancer: accumulating evidence from both familial and nonfamilial cases. , 2007, Cancer letters.

[9]  John D. Scott,et al.  A-kinase anchoring proteins take shape. , 2007, Current opinion in cell biology.

[10]  Francesmary Modugno,et al.  Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. , 2007, Cancer research.

[11]  Jaana M. Hartikainen,et al.  A common coding variant in CASP8 is associated with breast cancer risk , 2007, Nature Genetics.

[12]  K. Hemminki,et al.  The functional genetic variant Ile646Val located in the kinase binding domain of the A-kinase anchoring protein 10 is associated with familial breast cancer. , 2006, Carcinogenesis.

[13]  K. Ickstadt,et al.  Breast cancer: a candidate gene approach across the estrogen metabolic pathway , 2007, Breast Cancer Research and Treatment.

[14]  Julian Peto,et al.  Search for low penetrance alleles for colorectal cancer through a scan of 1467 non-synonymous SNPs in 2575 cases and 2707 controls with validation by kin-cohort analysis of 14 704 first-degree relatives. , 2006, Human molecular genetics.

[15]  S. Henikoff,et al.  Predicting the effects of amino acid substitutions on protein function. , 2006, Annual review of genomics and human genetics.

[16]  A. Ashworth,et al.  Inconsistent association between the STK15 F31I genetic polymorphism and breast cancer risk. , 2006, Journal of the National Cancer Institute.

[17]  R. Houlston,et al.  Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. , 2006, Blood.

[18]  Ju-Han Lee,et al.  BRAF mutation and AKAP9 expression in sporadic papillary thyroid carcinomas , 2006, Pathology.

[19]  T. Eisen,et al.  Variants in the GH-IGF axis confer susceptibility to lung cancer. , 2006, Genome research.

[20]  Alfons Meindl,et al.  Association of genetic variants in the Rho guanine nucleotide exchange factor AKAP13 with familial breast cancer. , 2006, Carcinogenesis.

[21]  R. Houlston,et al.  Variants in the ATM-BRCA 2-CHEK 2 axis predispose to chronic lymphocytic leukemia , 2006 .

[22]  John L Hopper,et al.  Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource , 2006, Breast Cancer Research.

[23]  P. Rao,et al.  Tissue transglutaminase interacts with protein kinase A anchor protein 13 in prostate cancer. , 2005, Urologic oncology.

[24]  K. Odunsi,et al.  A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer. , 2005, Gynecologic Oncology.

[25]  W. Lam,et al.  Alteration of AKAP220, an upstream component of the Rb pathway, in oral carcinogenesis , 2005, International journal of cancer.

[26]  P. Bugert,et al.  Re: Association of a common variant of the CASP8 gene with reduced risk of breast cancer. , 2005, Journal of the National Cancer Institute.

[27]  J. Chang-Claude,et al.  Serum Sex Steroids in Premenopausal Women and Breast Cancer Risk Within the European Prospective Investigation into Cancer and Nutrition (EPIC) , 2005 .

[28]  Barbara Burwinkel,et al.  Association of NCOA3 Polymorphisms with Breast Cancer Risk , 2005, Clinical Cancer Research.

[29]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[30]  G. Viglietto,et al.  A new mechanism of BRAF activation in human thyroid papillary carcinomas. , 2005, The Journal of clinical investigation.

[31]  M. Nikiforova,et al.  Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. , 2005, The Journal of clinical investigation.

[32]  P. Bugert,et al.  The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk , 2004, Breast Cancer Research.

[33]  L. Langeberg,et al.  A-kinase-anchoring proteins , 1993, Journal of Cell Science.

[34]  H. Brauch,et al.  Factors Modifying the Association Between Hormone-Replacement Therapy and Breast Cancer Risk , 2005, European Journal of Epidemiology.

[35]  J. Chang-Claude,et al.  Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). , 2005, Journal of the National Cancer Institute.

[36]  Tae-You Kim,et al.  AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity , 2004, Oncogene.

[37]  J. Peto,et al.  The search for low-penetrance cancer susceptibility alleles , 2004, Oncogene.

[38]  I. M. Jones,et al.  Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. , 2004, Genomics.

[39]  G. Tortora,et al.  Antisense Targeting Protein Kinase A Type I as a Drug for Integrated Strategies of Cancer Therapy , 2003, Annals of the New York Academy of Sciences.

[40]  D. Easton,et al.  EMGM Abstracts , 2003, Genetic epidemiology.

[41]  John L Hopper,et al.  Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. , 2003, Journal of the National Cancer Institute.

[42]  Susan S. Taylor,et al.  Amino acid variant in the kinase binding domain of dual-specific A kinase-anchoring protein 2: A disease susceptibility polymorphism , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[43]  N E Day,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.

[44]  W. Miller.  Regulatory Subunits of PKA and Breast Cancer , 2002, Annals of the New York Academy of Sciences.

[45]  L. Norton,et al.  Focus on breast cancer. , 2002, Cancer cell.

[46]  Douglas F. Easton,et al.  Polygenic susceptibility to breast cancer and implications for prevention , 2002, Nature Genetics.

[47]  A. Meindl,et al.  Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population , 2002, International journal of cancer.

[48]  N. Day,et al.  EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. , 1999, British journal of cancer.

[49]  Y. Cho‐Chung,et al.  cAMP-dependent protein kinase: role in normal and malignant growth. , 1995, Critical reviews in oncology/hematology.

[50]  P. Boyle,et al.  Background, rationale and protocol for a case-control-family study of breast cancer , 1994 .